MedImmune   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Gaithersburg MD United States (1988)
Status: Acquired by AstraZeneca (2007)

Organization Overview

First Clinical Trial
1997
NCT00807794
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MEDIMMUNE | MedImmune LLC | MedImmune Ltd | MEDIMMUNE ONCOLOGY | One MedImmune Way,Gaithersburg,Maryland,United States | One MedImmune Way Gaithersburg, MD 20878 United States of America